title: Life beyond bortezomib: increasing treatment options in refractory myeloma.
authors.affiliation: a Department of Hematology , Mayo Clinic , Rochester , MN , USA.
authors.forename: Rajshekhar
authors.initials: R
authors.lastname: Chakraborty
authors.affiliation: a Department of Hematology , Mayo Clinic , Rochester , MN , USA.
authors.forename: Morie A
authors.initials: MA
authors.lastname: Gertz
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib